Intermediate-affinity interleukin-2 receptor expression predicts CD56(bright) natural killer cell expansion after daclizumab treatment in the CHOICE study of patients with multiple sclerosis (Q46377533)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Intermediate-affinity interleukin-2 receptor expression predicts CD56(bright) natural killer cell expansion after daclizumab treatment in the CHOICE study of patients with multiple sclerosis |
scientific article |
Statements
1 reference
Intermediate-affinity interleukin-2 receptor expression predicts CD56(bright) natural killer cell expansion after daclizumab treatment in the CHOICE study of patients with multiple sclerosis (English)
1 reference
James P Sheridan
1 reference
Ying Zhang
1 reference
Katherine Riester
1 reference
Meina T Tang
1 reference
Lyubov Efros
1 reference
Jia Shi
1 reference
Jeffrey Harris
1 reference
Vladimir Vexler
1 reference
Jacob S Elkins
1 reference
1 August 2011
1 reference
1 reference
17
1 reference
12
1 reference
1441-1448
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference